Implications of identifying additional cerebral metastases during gamma knife radiosurgery

Toral R. Patel, Ali K. Ozturk, Jonathan P S Knisely, Veronica L. Chiang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction. Gamma Knife radiosurgery (GK-SRS) is commonly used to treat cerebral metastases. Although additional intracranial metastases are often found on the day of GK-SRS, the significance of finding them is unknown. Methods. A retrospective review of 133 patients undergoing GK-SRS for cerebral metastases was performed. The change in number of metastases detected between initial referral magnetic resonance imaging (MRI) and subsequent treatment MRI was quantified. Multivariate and Kaplan-Meier analyses were employed to examine the significance of identifying additional lesions. Results. Additional lesions were identified in 41 of patients. An increasing number of metastases on referral MRI (P = 0.001) and the presence of progressive systemic disease (P = 0.003) were predictive of identifying additional metastases. Median survival was 6.9 months for patients with additional metastases, compared to 12.1 months for patients without additional metastases (hazard ratio 1.56, P = 0.021). Conclusions. Identifying additional metastases on the day of GK-SRS may add important prognostic information.

Original languageEnglish (US)
Article number748284
JournalInternational Journal of Surgical Oncology
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Radiosurgery
Neoplasm Metastasis
Magnetic Resonance Imaging
Referral and Consultation
Kaplan-Meier Estimate
Survival

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Implications of identifying additional cerebral metastases during gamma knife radiosurgery. / Patel, Toral R.; Ozturk, Ali K.; Knisely, Jonathan P S; Chiang, Veronica L.

In: International Journal of Surgical Oncology, Vol. 2012, 748284, 2012.

Research output: Contribution to journalArticle

@article{77f38673c0f94f52ab049ba6b195b2af,
title = "Implications of identifying additional cerebral metastases during gamma knife radiosurgery",
abstract = "Introduction. Gamma Knife radiosurgery (GK-SRS) is commonly used to treat cerebral metastases. Although additional intracranial metastases are often found on the day of GK-SRS, the significance of finding them is unknown. Methods. A retrospective review of 133 patients undergoing GK-SRS for cerebral metastases was performed. The change in number of metastases detected between initial referral magnetic resonance imaging (MRI) and subsequent treatment MRI was quantified. Multivariate and Kaplan-Meier analyses were employed to examine the significance of identifying additional lesions. Results. Additional lesions were identified in 41 of patients. An increasing number of metastases on referral MRI (P = 0.001) and the presence of progressive systemic disease (P = 0.003) were predictive of identifying additional metastases. Median survival was 6.9 months for patients with additional metastases, compared to 12.1 months for patients without additional metastases (hazard ratio 1.56, P = 0.021). Conclusions. Identifying additional metastases on the day of GK-SRS may add important prognostic information.",
author = "Patel, {Toral R.} and Ozturk, {Ali K.} and Knisely, {Jonathan P S} and Chiang, {Veronica L.}",
year = "2012",
doi = "10.1155/2012/748284",
language = "English (US)",
volume = "2012",
journal = "International Journal of Surgical Oncology",
issn = "2090-1402",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Implications of identifying additional cerebral metastases during gamma knife radiosurgery

AU - Patel, Toral R.

AU - Ozturk, Ali K.

AU - Knisely, Jonathan P S

AU - Chiang, Veronica L.

PY - 2012

Y1 - 2012

N2 - Introduction. Gamma Knife radiosurgery (GK-SRS) is commonly used to treat cerebral metastases. Although additional intracranial metastases are often found on the day of GK-SRS, the significance of finding them is unknown. Methods. A retrospective review of 133 patients undergoing GK-SRS for cerebral metastases was performed. The change in number of metastases detected between initial referral magnetic resonance imaging (MRI) and subsequent treatment MRI was quantified. Multivariate and Kaplan-Meier analyses were employed to examine the significance of identifying additional lesions. Results. Additional lesions were identified in 41 of patients. An increasing number of metastases on referral MRI (P = 0.001) and the presence of progressive systemic disease (P = 0.003) were predictive of identifying additional metastases. Median survival was 6.9 months for patients with additional metastases, compared to 12.1 months for patients without additional metastases (hazard ratio 1.56, P = 0.021). Conclusions. Identifying additional metastases on the day of GK-SRS may add important prognostic information.

AB - Introduction. Gamma Knife radiosurgery (GK-SRS) is commonly used to treat cerebral metastases. Although additional intracranial metastases are often found on the day of GK-SRS, the significance of finding them is unknown. Methods. A retrospective review of 133 patients undergoing GK-SRS for cerebral metastases was performed. The change in number of metastases detected between initial referral magnetic resonance imaging (MRI) and subsequent treatment MRI was quantified. Multivariate and Kaplan-Meier analyses were employed to examine the significance of identifying additional lesions. Results. Additional lesions were identified in 41 of patients. An increasing number of metastases on referral MRI (P = 0.001) and the presence of progressive systemic disease (P = 0.003) were predictive of identifying additional metastases. Median survival was 6.9 months for patients with additional metastases, compared to 12.1 months for patients without additional metastases (hazard ratio 1.56, P = 0.021). Conclusions. Identifying additional metastases on the day of GK-SRS may add important prognostic information.

UR - http://www.scopus.com/inward/record.url?scp=84863882818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863882818&partnerID=8YFLogxK

U2 - 10.1155/2012/748284

DO - 10.1155/2012/748284

M3 - Article

VL - 2012

JO - International Journal of Surgical Oncology

JF - International Journal of Surgical Oncology

SN - 2090-1402

M1 - 748284

ER -